[VIVO] YoY Quarter Result on 31-Dec-2021 [#Q1]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
04-Feb-2022
Financial Year
2022
Quarter
31-Dec-2021 [#Q1]
Profit Trend
QoQ- 130.43%
YoY- -42.72%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 56,902 88,341 92,917 47,421 51,480 52,283 46,809 3.30%
PBT -29,097 19,751 34,248 4,026 10,476 7,658 9,659 -
Tax 724 4,411 7 1,199 2,370 1,356 3,380 -22.63%
NP -29,821 15,340 26,779 2,827 8,106 6,302 6,279 -
Tax Rate - -22.33% -0.02% -29.78% -22.62% -17.71% -34.99% -
Total Cost 86,723 73,001 66,138 44,594 43,374 45,981 40,530 13.51%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -52.41 17.36 28.82 5.96 15.75 12.05 13.41 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.68 0.35 0.62 0.07 0.19 0.15 0.15 -
EPS Diluted -0.68 0.35 0.61 0.07 0.19 0.15 0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.